CTT PHARMACEUTICAL HOLDINGS, INC.

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 13. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 13
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
CTT PHARMACEUTICAL HOLDINGS, INC.CEOOpen-market buy$45510,100 sharesSep 29, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEO$455Buy · Sep 29Open-market buy10,100Sep 29, 2026
CTT PHARMACEUTICAL HOLDINGS, INC.CEOOpen-market buy$1873,400 sharesSep 28, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEO$187Buy · Sep 28Open-market buy3,400Sep 28, 2026
CTT PHARMACEUTICAL HOLDINGS, INC.CEOOpen-market buy$45510,100 sharesSep 22, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEO$455Buy · Sep 22Open-market buy10,100Sep 22, 2026
CTT PHARMACEUTICAL HOLDINGS, INC.CEOOpen-market buy$52310,900 sharesSep 16, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEO$523Buy · Sep 16Open-market buy10,900Sep 16, 2026
CTT PHARMACEUTICAL HOLDINGS, INC.CEOOpen-market buy$1753,500 sharesSep 10, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEO$175Buy · Sep 10Open-market buy3,500Sep 10, 2026